Dopamine transporter (DAT) SPECT is an established diagnostic procedure in dementia diagnostics, yet its prognostic value is currently unknown.
Objective:
We evaluated the prognostic value of DAT SPECT in patients assessed for differential diagnosis of dementia.
Methods:
We included all patients who had received DAT SPECT for differential diagnosis of dementia from 10/2008 to 06/2016 at our site and whose survival status could be obtained in 09/2019. Clinical SPECT reports, categorizing scans into positive or negative for nigrostriatal degeneration (NSD), were tested for their prognostic value (Cox regressions, adjusted for age and sex). In addition, an automated region-of-interest analysis (striatum, occipital cortex as reference) was performed.
Results:
Median follow-up of 97 included patients was 6.6 years. Patients with NSD had a significantly higher mortality risk than those without NSD (HR = 3.6 [2.0–6.7], p < 0.001). Results were confirmed by region-of-interest analysis: higher mortality risk was associated with lower striatal DAT binding (HR = 1.8 per standard deviation loss).
Conclusion:
Beyond its established utility in dementia diagnostics, DAT SPECT also conveys important prognostic information.
ThomasA, AttemsJ, CollobyS, O’BrienJ, McKeithI, WalkerR, LeeL, BurnD, LettD, WalkerZ (2017) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology88, 276–283.
3.
Graff-RadfordJ, LesnickT, BoeveB, PrzybelskiS, JonesD, SenjemM, GunterJ, FermanT, KnopmanD, MurrayM, DicksonD, SarroL, JackCJ, PetersenR, KantarciK (2016) Predicting survival in dementia with Lewy bodies with hippocampal volumetry. Mov Disord31, 989–994.
4.
KansalK, MareddyM, SloaneK, MincA, RabinsP, McGreadyJ, OnyikeC (2016) Survival in frontotemporal dementia phenotypes: A meta-analysis. Dement Geriatr Cogn Disord41, 109–122.
5.
BrodatyH, SeeherK, GibsonL (2012) Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr24, 1034–1045.
6.
CercyS, BylsmaF (1997) Lewy bodies and progressive dementia: A critical review and meta-analysis. J Int Neuropsychol Soc3, 179–194.
7.
StubendorffK, HanssonO, MinthonL, LondosE (2011) Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer’s disease–measured from a fixed cognitive level. Dement Geriatr Cogn Disord32, 408–416.
8.
ToddS, BarrS, RobertsM, PassmoreA (2013) Survival in dementia and predictors of mortality: A review. Int J Geriatr Psychiatry28, 1109–1124.
9.
RizzoG, ArcutiS, CopettiM, AlessandriaM, SavicaR, FontanaA, LiguoriR, LogroscinoG (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis. J Neurol Neurosurg Psychiatry89, 358–366.
10.
BeachT, MonsellS, PhillipsL, KukullW (2012) Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol71, 266–273.
11.
MeyerP, WinzO, DafotakisM, WernerC, KrohnT, SchaferW (2011) Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images. Q J Nucl Med Mol Imaging55, 301–309.
12.
WinzO, HellwigS, MixM, WeberW, MottaghyF, SchaferW, MeyerP (2012) Image quality and data quantification in dopamine transporter SPECT: Advantage of 3-dimensional OSEM reconstruction?Clin Nucl Med37, 866–871.
13.
Tzourio-MazoyerN, LandeauB, PapathanassiouD, CrivelloF, EtardO, DelcroixN, MazoyerB, JoliotM (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage15, 273–289.
14.
FinkelsteinD, MuzikanskyA, SchoenfeldD (2003) Comparing survival of a sample to that of a standard population. J Natl Cancer Inst95, 1434–1439.
15.
McKeithI, DicksonD, LoweJ, EmreM, O’BrienJ, FeldmanH, CummingsJ, DudaJ, LippaC, PerryE, AarslandD, AraiH, BallardC, BoeveB, BurnD, CostaD, Del SerT, DuboisB, GalaskoD, GauthierS, GoetzC, Gomez-TortosaE, HallidayG, HansenL, HardyJ, IwatsuboT, KalariaR, KauferD, KennyR, KorczynA, KosakaK, LeeV, LeesA, LitvanI, LondosE, LopezO, MinoshimaS, MizunoY, MolinaJ, Mukaetova-LadinskaE, PasquierF, PerryR, SchulzJ, TrojanowskiJ, YamadaM (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology65, 1863–1872.
16.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
17.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr., KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
18.
SpehlTS, FringsL, HellwigS, WeillerC, HullM, MeyerPT, AmtageF (2015) Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer’s dementia. Clin Nucl Med40, e27–33.
19.
Garcia-PtacekS, FarahmandB, KåreholtI, ReligaD, CuadradoML, EriksdotterM (2014) Mortality risk after dementia diagnosis by dementia type and underlying factors: A cohort of 15,209 patients based on the Swedish Dementia Registry. J Alzheimers Dis41, 467–477.
20.
ArmstrongMJ, AllianceS, CorsentinoP, DeKoskyST, TaylorA (2019) Cause of death and end-of-life experiences in individuals with dementia with Lewy bodies. J Am Geriatr Soc67, 67–73.
21.
Williams-GrayC, MasonS, EvansJ, FoltynieT, BrayneC, RobbinsT, BarkerR (2013) The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry84, 1258–1264.
22.
SuttrupI, WarneckeT (2016) Dysphagia in Parkinson’s disease. Dysphagia31, 24–32.
23.
MüllerJ, WenningGK, VernyM, McKeeA, ChaudhuriKR, JellingerK, PoeweW, LitvanI (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol58, 259–264.
24.
FereshtehnejadSM, DamangirS, CermakovaP, AarslandD, EriksdotterM, ReligaD (2014) Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: A linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther6, 65.
